Literature DB >> 8356939

Hyperaggregation of platelets detected by whole blood platelet aggregometry in newly diagnosed noninsulin-dependent diabetes mellitus.

S Mandal1, R Sarode, S Dash, R J Dash.   

Abstract

Twenty-five newly diagnosed cases of noninsulin-dependent diabetes mellitus were studied at the time of diagnosis and again after metabolic control of diabetes was achieved (approximately 3 months later) for platelet aggregation abnormalities in whole blood by the impedance method. Adenosine diphosphate in 10 and 20 mumol/L final concentrations and arachidonic acid in 25 and 50 mmol/L final concentrations were used as agonists. Patients had a significant hyperaggregation of platelets (P < 0.01) at the time of diagnosis compared with age-matched healthy control subjects. After metabolic control of blood glucose was achieved using oral hypoglycemic agents (n = 20) and diet regulation alone (n = 5), there was a significant decrease in platelet aggregation (P < 0.01). There was a positive relationship between blood glucose levels and whole blood platelet aggregation with adenosine diphosphate (P < 0.02 and < 0.05, with 10 mumol/L and 20 mumol/L, respectively), but there was no relationship between aggregation and glycosylated hemoglobin levels. Thus, platelet hyperaggregation was present even at the time of diagnosis in patients with diabetes mellitus in the absence of any vascular complications, and there was significant improvement in platelet hyperaggregation after metabolic control of blood glucose levels was achieved.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8356939     DOI: 10.1093/ajcp/100.2.103

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

1.  Impact of inflammatory state and metabolic control on responsiveness to dual antiplatelet therapy in type 2 diabetics after PCI: prognostic relevance of residual platelet aggregability in diabetics undergoing coronary interventions.

Authors:  Tobias Geisler; Karin Mueller; Simon Aichele; Boris Bigalke; Konstantinos Stellos; Patrick Htun; Elena Ninci; Susanne Fateh-Moghadam; Andreas E May; Meinrad Gawaz
Journal:  Clin Res Cardiol       Date:  2010-06-06       Impact factor: 5.460

2.  Mean platelet volume and platelet counts in type 2 diabetes: mellitus on treatment and non-diabetic mellitus controls in Lagos, Nigeria.

Authors:  Akinbami Akinsegun; Dada Akinola Olusola; John-Olabode Sarah; Oshinaike Olajumoke; Adediran Adewumi; Odesanya Majeed; Ogbera Anthonia; Uche Ebele; Okunoye Olaitan; Arogundade Olanrewaju; Aile Kingsley
Journal:  Pan Afr Med J       Date:  2014-05-12

3.  Platelet function testing to predict hyporesponsiveness to clopidogrel in patients with chest pain seen in the emergency department.

Authors:  Rakesh K Sharma; Stephen W Erickson; Rohit Sharma; Donald J Voelker; Hanumanth K Reddy; Harvinder Dod; James D Marsh
Journal:  Vasc Health Risk Manag       Date:  2013-05-01

4.  Compression force sensing regulates integrin αIIbβ3 adhesive function on diabetic platelets.

Authors:  Lining Ju; James D McFadyen; Saheb Al-Daher; Imala Alwis; Yunfeng Chen; Lotte L Tønnesen; Sophie Maiocchi; Brianna Coulter; Anna C Calkin; Eric I Felner; Neale Cohen; Yuping Yuan; Simone M Schoenwaelder; Mark E Cooper; Cheng Zhu; Shaun P Jackson
Journal:  Nat Commun       Date:  2018-03-14       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.